EFPIA Patients W.A.I.T. Indicator
Patients W.A.I.T. 2020 survey results, which provide a benchmark of the rate of availability and time to availability in European countries (34 countries in total).
The EFPIA/CRA report analyses and documents 10 interrelated factors that explain unavailability and delays, which are rooted in the medicines access systems and processes in the EU member states and the corresponding impact on commercial decision-making.